Forty‐two infants (20 males, 22 females) with classical phenylketonuria (PKU) entered a prospective, double‐blind, randomized study to investigate the effects on biochemical and physiological outcomes of a phenylalanine‐free infant formula containing a fat blend supplemented with the long‐chain polyunsaturated fatty acids (LC‐PUFA), docosahexaenoic acid (DHA, C22:6n‐3), and arachidonic acid (AA, C20:4n‐6). Between entry and 20 weeks (entry and 1y) of age, median DHA levels in erythrocyte membrane phospholipids decreased by 15% (22%) in the LC‐PUFA supplemented group (n=21) and by 61% (64%) in the control group (p<0.001; n=18). A dietary supply of LC‐PUFA in infants with PKU prevents the decline in DHA levels associated with a diet supplying minimal sources of LC‐PUFA. DHA status in turn, independent of diet, may influence the maturation of the visual system in infants with PKU.